Coronavirus scientists have announced a major breakthrough that a new drug combination is showing signs of having the ability to ‘suppress infection’.
Using both nafamostat and Pegasys (IFNα) drugs together at the same time is providing positive results of covid treatment. The groundbreaking discovery has been developed by researchers at the Norwegian University of Science and Technology (NTNU).
This new combination of readily available drugs could mean that countries across the globe could battle the pandemic more effectively.
Nafamostat is presently used in certain therapies against COVID-19 and is being extensively tested in Japan. And Pegasys (IFNα) is already being used to fight hepatitis C, a virus that can infect the liver.Professor.